BY27 is a potent and selective BET BD2 inhibitor (Ki: 3.1 nM) with anti-cancer activity and shows 38, 5, 7, and 21-fold BD1/BD2 selectivity for BRD2, BRD3, BRD4, and BRDT.

2247236-59-3

C22H21ClN6

404.9

BY27

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years